Capital Management Corp Va Lowers stake in Albemarle Corporation (ALB)

Albemarle Corporation (ALB) : Capital Management Corp Va reduced its stake in Albemarle Corporation by 17.96% during the most recent quarter end. The investment management company now holds a total of 111,761 shares of Albemarle Corporation which is valued at $9,500,803 after selling 24,460 shares in Albemarle Corporation , the firm said in a disclosure report filed with the SEC on Jul 20, 2016.Albemarle Corporation makes up approximately 3.50% of Capital Management Corp Va’s portfolio.

Other Hedge Funds, Including , Hartford Investment Management Co added ALB to its portfolio by purchasing 27,416 company shares during the most recent quarter which is valued at $2,330,634. Albemarle Corporation makes up approx 0.05% of Hartford Investment Management Co’s portfolio.Leavell Investment Management boosted its stake in ALB in the latest quarter, The investment management firm added 999 additional shares and now holds a total of 21,999 shares of Albemarle Corporation which is valued at $1,905,553. Albemarle Corporation makes up approx 0.27% of Leavell Investment Management’s portfolio.Benjamin F. Edwards Company boosted its stake in ALB in the latest quarter, The investment management firm added 7 additional shares and now holds a total of 1,438 shares of Albemarle Corporation which is valued at $123,021. Albemarle Corporation makes up approx 0.02% of Benjamin F. Edwards Company’s portfolio.Integrated Investment Consultants boosted its stake in ALB in the latest quarter, The investment management firm added 20 additional shares and now holds a total of 630 shares of Albemarle Corporation which is valued at $50,337. Albemarle Corporation makes up approx 0.03% of Integrated Investment Consultants’s portfolio.

Albemarle Corporation opened for trading at $86.04 and hit $86.89 on the upside on Wednesday, eventually ending the session at $86.62, with a gain of 0.81% or 0.7 points. The heightened volatility saw the trading volume jump to 9,48,546 shares. Company has a market cap of $9,727 M.

On the company’s financial health, Albemarle Corporation reported $1.12 EPS for the quarter, beating the analyst consensus estimate by $ 0.26 according to the earnings call on May 10, 2016. Analyst had a consensus of $0.86. The company had revenue of $865.40 million for the quarter, compared to analysts expectations of $814.81 million. The company’s revenue was down -2.1 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.17 EPS.

Investors should note that on Jul 11, 2016, Albemarle Corporation announced a cash dividend of $0.3050. The company’s management has announced Sep 13, 2016 as the ex-dividend date and fixed the record date on Sep 15, 2016. The payable date has been fixed on Oct 3, 2016.

Many Wall Street Analysts have commented on Albemarle Corporation. Company shares were Reiterated by Deutsche Bank on Jun 20, 2016 to “Buy”, Firm has raised the Price Target to $ 94 from a previous price target of $84 .Company shares were Reiterated by Deutsche Bank on May 12, 2016 to “Buy”, Firm has raised the Price Target to $ 84 from a previous price target of $72 .

Albemarle Corporation (Albemarle) is a developer manufacturer and marketer of specialty chemicals across a range of end markets including the petroleum refining consumer electronics plastics/packaging construction automotive lubricants pharmaceuticals crop protection food-safety and custom chemistry services markets. The Company operates through two segments: Performance Chemicals and Catalyst Solutions. As of December 31 2014 the Performance Chemicals segment includes the Fire Safety Solutions Specialty Chemicals and Fine Chemistry Services product categories. As of December 31 2014 the Catalyst Solutions segment includes the Refinery Catalyst Solutions and Performance Catalyst Solutions product categories.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *